Table 1.
Vaccine efficacy against various end-points in per-protocol and intention to treat cohorts from phase III RCTs-Risk ratio of zero indicates 100percent efficacy, whereas one indicates no difference with controls[12]

Vaccine efficacy against various end-points in per-protocol and intention to treat cohorts from phase III RCTs-Risk ratio of zero indicates 100percent efficacy, whereas one indicates no difference with controls[12]
